Oruka Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Oruka Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Oruka Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 35M shares, a 143% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 35M +20.6M +143% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 14.5M +97K +0.67% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 14.5M +91K +0.63% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 14.5M +91K +0.63% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 14.4M 0 0% Sep 30, 2023 10-Q 2023-10-18
Q2 2023 14.4M 0 0% Jun 30, 2023 10-Q 2023-07-21
Q1 2023 14.4M 0 0% Mar 31, 2023 10-Q 2023-04-24
Q4 2022 14.4M 0 0% Dec 31, 2022 10-K 2024-02-01
Q3 2022 14.4M 0 0% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 14.4M 0 0% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 14.4M 0 0% Mar 31, 2022 10-Q 2022-05-02
Q4 2021 14.4M +4.86M +50.9% Dec 31, 2021 10-K 2023-02-24
Q3 2021 14.4M +5.12M +55.2% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 14.4M +12.1M +535% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 14.4M +12.8M +804% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 9.55M +7.95M +499% Dec 31, 2020 10-K 2022-03-14
Q3 2020 9.29M +7.69M +483% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 2.27M +812K +55.8% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 1.59M +495K +45.1% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 1.59M +821K +106% Dec 31, 2019 10-K 2021-03-18
Q3 2019 1.59M -12.3M -88.6% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 1.46M -12.5M -89.5% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 1.1M -12.8M -92.1% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 774K -11M -93.4% Dec 31, 2018 10-K 2020-02-18
Q3 2018 13.9M +2.17M +18.5% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 13.9M +3.81M +37.6% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 13.9M +4.74M +51.7% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 11.8M +2.69M +29.6% Dec 31, 2017 10-K 2019-02-27
Q3 2017 11.8M +2.67M +29.4% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 10.1M +1.05M +11.6% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 9.17M +116K +1.28% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 9.08M +31.1K +0.34% Dec 31, 2016 10-K 2018-03-22
Q3 2016 9.08M +30.9K +0.34% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 9.07M -54.2M -85.7% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 9.06M -12.1M -57.3% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 9.05M +6.03M +200% Dec 31, 2015 10-K 2017-03-21
Q3 2015 9.05M -12.1M -57.2% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 63.2M +42.2M +201% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 21.2M +197K +0.94% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 3.02M -12.7M -80.7% Dec 31, 2014 10-K 2016-03-17
Q3 2014 21.1M +7.95M +60.2% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 21M +10.9M +108% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 21M +17.8M +559% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 15.7M +13M +490% Dec 31, 2013 10-K 2015-03-19
Q3 2013 13.2M -1.42M -9.74% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 10.1M -2.09M -17.1% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 3.19M -9M -73.9% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 2.66M +630K +31% Dec 31, 2012 10-K 2014-03-20
Q3 2012 14.6M +4.1M +39% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 12.2M +1.67M +15.9% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 12.2M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 2.03M -6.8M -77% Dec 31, 2011 10-K 2013-03-21
Q3 2011 10.5M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 10.5M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 8.83M Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.